RecruitingNot ApplicableNCT06417996

Biobeat Digital Home Monitoring Feasibility

Postoperative Digital Care Home Monitoring


Sponsor

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Enrollment

48 participants

Start Date

Feb 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

To assess the feasibility of evaluating postoperative home monitoring with Biobeat digital monitoring. The investigators hypothesize that the Biobeat digital home monitoring platform will lead to a decrease in unplanned visits to the ED (Emergency Department). In addition, patients' quality of life is postulated to be improved compared to patients receiving the current standard of care without home monitoring.


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • Patient willing to provide informed consent
  • Wi-fi or cellular connectivity at the patient's home
  • Patient undergoing elective lung cancer surgery
  • Patient familiar/comfortable with the use of technology such as online banking.

Exclusion Criteria1

  • \- Patients who are not comfortable with the use of technology.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERDigital Group

Once patients are ready for discharge, patients in the digital group will be sent home with the Biobeat digital monitoring kit with written \& oral instructions on how it will be used in maintaining continuity of care which will track ECG (electrocardiogram), HR, NIBP, SPO2, and pain scores. A continuous recording and two-lead ECG patch will be applied and activated at the time of discharge to identify any paroxysmal atrial fibrillation.


Locations(1)

London Health Sciences Centre

London, Ontario, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06417996


Related Trials